قالب وردپرس درنا توس
Home / Health / The spokesperson urged the FDA to take a positive attitude towards switching to drugs and COVID

The spokesperson urged the FDA to take a positive attitude towards switching to drugs and COVID



Spokesperson Manila Velasco (Lord Allan Velasco) said that the Department of Health (DOH) and the Food and Drug Administration (FDA) should be more proactive in studying the safety of ivermectin in the prevention and treatment of COVID-19 And effectiveness.

Velasco said in a statement that the Filipinos have “eagerly hoped for a cure” and that the government should inform the public of all the options for preventing and treating the disease, which is currently raging in the national capital region and neighboring provinces.

He said: “With the surge in cases and more deaths, regulators should find it necessary to study the safety and effectiveness of ivermectin and other drugs that switch to COVID-1

9. This is a desperate moment. Take a more proactive approach to regulatory measures. People need other remedial measures to prevent or treat COVID-19.”

survivor

Deputy Speaker and Representative of Bagong Henerasyon Bernadette Herrera, 1Pacman Representative Enrico Pineda and Representative Anakalusugan Michael Defensor promoted the use of this drug for COVID-19 treatment.

Both Pineda and Defensor are survivors of COVID-19. Defensor said he took ivermectin as well as vitamins and supplements during home isolation.

Previously, the FDA closed the laboratory of Dr. Allan Landrito, who was selling the ivermectin compound to COVID-19 patients.

In a hearing in the House of Representatives, the FDA said it will discuss with drug manufacturers how to fast track pending applications for ivermectin as a treatment for COVID-19.

The US Department of Health said that more scientific evidence is needed to prove the drug’s efficacy against the virus.

But Herrera reiterated the position of ivermectin advocates that ivermectin is a cheap and effective alternative to COVID-19 and can “significantly reduce” deaths. She said that as a regulatory agency, the FDA should remain “open” to ivermectin because it is much cheaper than other drugs currently used to treat COVID-19.

For more news about the novel coronavirus, please click here.

You need to know about the coronavirus.

For more information about COVID-19, please call the DOH hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontiers and is still accepting cash donations, deposit them into Banco de Oro (BDO) current account #007960018860 or use this money to donate via PayMaya Associate .

continue reading

For feedback, complaints or inquiries, please contact us.




Source link